Burning mouth syndrome
RecruitingStudy on Clonazepam for Treating Burning Mouth Syndrome in Patients
- Disease:Burning mouth syndrome
- Substances:Clonazepam
Sweden- Participants:18–64 years · 65+ years
- Substances:Clonazepam
- Sponsor:Malmoe Universitet
Rare diseases
Investigational molecules
Locations
Bassanggatan 2, 211 19 Malmo, Sweden
Malmoe Universitet in Malmo, Sweden specialises in clinical trials of conditions such as Burning mouth syndrome, Diabetic foot, and other specialisations. This site conducts important research.
Research in this area focuses on xerotic skin and diabetic foot dryness, with studies designed to assess whether new topical creams can improve skin condition more effectively than a comparator. The work centers on dermatology and connective tissue health, aiming to support better symptom relief and everyday comfort for people living with diabetes.
This research reflects a practical interest in improving skin care for a common diabetes-related problem, with a clear focus on treatment effectiveness and patient well-being.
The second line of research at Malmoe Universitet addresses burning mouth syndrome, a painful condition affecting the mouth and jaw region. These studies explore whether clonazepam and related treatment approaches can reduce pain intensity, ease sensory changes, and improve jaw function, while also considering patients’ treatment preferences and experiences.
Overall, this research combines orofacial pain care with patient-centered evaluation, aiming to better understand both the clinical effects and the lived experience of treatment.
Clinical trials currently enrolling participants at this site.
Sweden
SwedenGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.